Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jenna Demedis

Concepts (153)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cancer Survivors
14
2026
348
3.430
Why?
Sexual Dysfunction, Physiological
6
2026
74
2.570
Why?
Neoplasms
23
2026
2954
2.560
Why?
Hyperglycemia
4
2023
384
1.240
Why?
Sexual Health
3
2026
67
1.130
Why?
Hodgkin Disease
2
2023
173
0.920
Why?
Lymphoma
2
2023
251
0.910
Why?
Hematopoietic Stem Cell Transplantation
4
2022
704
0.830
Why?
Survivorship
3
2025
62
0.790
Why?
Patient Reported Outcome Measures
3
2024
516
0.770
Why?
Adolescent
30
2026
22557
0.710
Why?
Young Adult
21
2026
14330
0.680
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2023
299
0.590
Why?
Child
30
2026
22693
0.560
Why?
Hypoglycemia
2
2022
490
0.460
Why?
Child, Preschool
13
2026
11913
0.410
Why?
Medical Oncology
3
2026
345
0.390
Why?
Sarcoma, Ewing
2
2025
103
0.350
Why?
Humans
40
2026
146342
0.350
Why?
Tinnitus
1
2021
22
0.340
Why?
Blood Glucose
4
2023
2360
0.320
Why?
Eye Neoplasms
1
2021
31
0.320
Why?
Male
24
2026
73396
0.320
Why?
Adult
16
2026
41087
0.310
Why?
Risk Factors
8
2026
10921
0.310
Why?
Infant
8
2026
10114
0.300
Why?
Castleman Disease
1
2019
16
0.290
Why?
Female
25
2026
79499
0.280
Why?
Quality of Life
6
2024
3200
0.270
Why?
Blood Glucose Self-Monitoring
2
2022
704
0.260
Why?
Survivors
3
2023
526
0.260
Why?
Neoplasm Proteins
1
2021
444
0.260
Why?
Herpesviridae Infections
1
2019
147
0.260
Why?
Transplantation Conditioning
1
2019
193
0.260
Why?
Leukemia
1
2019
246
0.250
Why?
Immunoconjugates
1
2018
138
0.250
Why?
Mass Screening
2
2026
1307
0.240
Why?
Personnel Staffing and Scheduling
1
2017
102
0.240
Why?
Multicenter Studies as Topic
2
2025
417
0.230
Why?
Sex Education
1
2026
33
0.230
Why?
Carcinoma, Squamous Cell
1
2021
628
0.230
Why?
Nuclear Proteins
1
2021
740
0.230
Why?
Head and Neck Neoplasms
1
2021
563
0.220
Why?
Workload
1
2017
170
0.220
Why?
Genetic Heterogeneity
1
2025
67
0.210
Why?
Pregnancy, Unplanned
1
2025
48
0.210
Why?
Clonal Evolution
1
2025
47
0.210
Why?
Primary Health Care
2
2025
1776
0.210
Why?
Retrospective Studies
7
2023
17438
0.200
Why?
Febrile Neutropenia
1
2023
6
0.200
Why?
Mixed Tumor, Malignant
1
2023
4
0.200
Why?
Perception
1
2026
373
0.200
Why?
Symptom Assessment
1
2024
138
0.200
Why?
Antibiotic Prophylaxis
1
2025
140
0.190
Why?
Adipose Tissue, Brown
1
2023
60
0.190
Why?
Infant, Newborn
4
2026
6460
0.190
Why?
Fluorodeoxyglucose F18
1
2023
164
0.180
Why?
Urinary Tract
1
2023
47
0.180
Why?
Neoplasms, Germ Cell and Embryonal
1
2023
76
0.180
Why?
Bone Neoplasms
1
2025
272
0.180
Why?
Testicular Neoplasms
1
2023
108
0.180
Why?
Patients
1
2024
183
0.180
Why?
Positron-Emission Tomography
1
2023
343
0.170
Why?
Single-Cell Analysis
1
2025
370
0.170
Why?
Rhabdoid Tumor
1
2023
99
0.170
Why?
Lung Diseases
1
2018
787
0.170
Why?
Education, Medical, Graduate
1
2017
568
0.170
Why?
Bacterial Infections
1
2023
247
0.170
Why?
Vitamin D Deficiency
1
2013
189
0.170
Why?
Pediatrics
2
2026
1124
0.170
Why?
Qualitative Research
3
2023
1734
0.170
Why?
Internet
1
2026
660
0.170
Why?
Bacteremia
1
2023
218
0.170
Why?
Algorithms
1
2019
1849
0.170
Why?
Incidence
2
2023
2936
0.170
Why?
RNA, Neoplasm
1
2021
76
0.160
Why?
Prognosis
5
2025
4351
0.160
Why?
Electronic Health Records
1
2019
1210
0.160
Why?
Circulating Tumor DNA
1
2021
50
0.160
Why?
Biomarkers, Tumor
2
2025
1339
0.160
Why?
Guideline Adherence
1
2025
594
0.160
Why?
Registries
1
2019
2400
0.150
Why?
Curriculum
1
2017
1079
0.150
Why?
Mutation
1
2021
4093
0.150
Why?
Clinical Trials as Topic
1
2024
1064
0.140
Why?
Hospitalization
2
2026
2475
0.140
Why?
Overweight
1
2023
614
0.130
Why?
Glucose
1
2023
1053
0.130
Why?
Sepsis
1
2023
669
0.130
Why?
Antineoplastic Agents
1
2018
2219
0.120
Why?
Caregivers
1
2025
1080
0.120
Why?
Health Promotion
1
2023
786
0.120
Why?
Internship and Residency
1
2017
1281
0.120
Why?
Practice Patterns, Physicians'
1
2025
1408
0.110
Why?
Emergency Service, Hospital
1
2026
2363
0.100
Why?
Semen
1
2023
21
0.100
Why?
Diabetes Mellitus, Type 1
1
2020
3930
0.090
Why?
Follow-Up Studies
3
2025
5439
0.090
Why?
Survival Rate
2
2019
2092
0.080
Why?
Cardiovascular Diseases
1
2023
2219
0.080
Why?
Prevalence
2
2021
2861
0.080
Why?
Computer Systems
1
2020
54
0.080
Why?
Radiotherapy
1
2021
209
0.080
Why?
Calibration
1
2020
154
0.070
Why?
Obesity
1
2023
3131
0.070
Why?
Anti-Bacterial Agents
3
2025
1942
0.070
Why?
Herpesvirus 8, Human
1
2019
67
0.070
Why?
Patient Outcome Assessment
1
2019
129
0.070
Why?
Disease Susceptibility
1
2019
339
0.070
Why?
Combined Modality Therapy
1
2021
1271
0.070
Why?
Neoadjuvant Therapy
1
2021
475
0.060
Why?
Survival Analysis
1
2020
1378
0.060
Why?
Grounded Theory
1
2017
47
0.060
Why?
Middle Aged
2
2026
36619
0.060
Why?
Disease Management
1
2019
651
0.050
Why?
Equivalence Trials as Topic
1
2025
35
0.050
Why?
Recurrence
1
2018
1133
0.050
Why?
Neoplastic Cells, Circulating
1
2025
81
0.050
Why?
Treatment Outcome
2
2020
11821
0.050
Why?
Neoplasm Staging
1
2018
1488
0.050
Why?
Tennessee
1
2013
57
0.050
Why?
Focus Groups
1
2017
588
0.050
Why?
Critical Pathways
1
2024
104
0.050
Why?
Sequence Analysis, RNA
1
2025
441
0.050
Why?
Fatigue
1
2024
363
0.040
Why?
Fever
1
2023
322
0.040
Why?
Age Factors
1
2019
3347
0.040
Why?
Fertility
1
2023
174
0.040
Why?
Prospective Studies
2
2025
8123
0.040
Why?
Proto-Oncogene Protein c-fli-1
1
2021
30
0.040
Why?
RNA-Binding Protein EWS
1
2021
31
0.040
Why?
Tumor Microenvironment
1
2025
747
0.040
Why?
Translocation, Genetic
1
2021
127
0.040
Why?
Interpersonal Relations
1
2023
387
0.040
Why?
Self Report
1
2024
870
0.040
Why?
Patient Education as Topic
1
2025
770
0.040
Why?
Oncogene Proteins, Fusion
1
2021
213
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2025
1432
0.040
Why?
Personal Satisfaction
1
2020
218
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
1998
0.030
Why?
Gene Expression Profiling
1
2025
1792
0.030
Why?
Polymerase Chain Reaction
1
2021
1031
0.030
Why?
Inflammation
1
2019
2919
0.030
Why?
Communication
1
2023
980
0.030
Why?
Practice Guidelines as Topic
1
2025
1591
0.030
Why?
Case-Control Studies
1
2013
3647
0.030
Why?
Early Detection of Cancer
1
2021
506
0.030
Why?
Time Factors
1
2017
7109
0.030
Why?
Telemedicine
1
2025
966
0.030
Why?
Reproducibility of Results
1
2021
3416
0.020
Why?
Transcription Factors
1
2021
1730
0.020
Why?
Surveys and Questionnaires
1
2025
6073
0.020
Why?
Pregnancy
1
2025
7230
0.020
Why?
Demedis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)